The healthcare distributor projects 2027 earnings growth following an 18% adjusted EPS increase in fiscal 2026.
McKesson forecast fiscal 2027 adjusted earnings per share between $43.80 and $44.60. The guidance follows an 18% year-over-year increase in adjusted EPS for fiscal 2026, reflecting strong operational performance.
The company reported solid fourth-quarter results, capping a year of growth. Fiscal 2026 adjusted EPS growth outpaced prior periods, driven by operational efficiency and strategic initiatives.
McKesson also announced plans to advance its Medical-Surgical business separation, aligning with long-term strategic goals.